CTI BioPharma
CTIC
#5622
Rank
NZ$2.07 B
Marketcap
NZ$15.73
Share price
0.00%
Change (1 day)
33.17%
Change (1 year)

CTI BioPharma (CTIC) - Total debt

Total debt on the balance sheet as of March 2023 : NZ$84.63 Million

According to CTI BioPharma 's latest financial reports the company's total debt is NZ$84.63 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

CTI BioPharma - Total debt on balance sheet (from 1997 to 2023)

Total debt by year

Year Total debt Change
2022-12-31NZ$78.68 M6.31%
2021-12-31NZ$74.01 M916.28%
2020-12-31NZ$7.28 M-59.99%
2019-12-31NZ$18.2 M-13.27%
2018-12-31NZ$20.98 M6.33%
2017-12-31NZ$19.73 M-29.01%
2016-12-31NZ$27.8 M-66.4%
2015-12-31NZ$82.74 M273.08%
2014-12-31NZ$22.17 M36.96%
2013-12-31NZ$16.19 M
2012-12-31N/A
2010-12-31NZ$36.59 M-59.31%
2009-12-31NZ$89.92 M-64.27%
2008-12-31NZ$0.25 B29.99%
2007-12-31NZ$0.19 B-18.19%
2006-12-31NZ$0.23 B-30.77%
2005-12-31NZ$0.34 B24.11%
2004-12-31NZ$0.27 B-6.68%
2003-12-31NZ$0.29 B31.63%
2002-12-31NZ$0.22 B-47.86%
2001-12-31NZ$0.43 B7344.21%
2000-12-31NZ$5.77 M-20.55%
1999-12-31NZ$7.27 M-24.86%
1998-12-31NZ$9.67 M47.78%
1997-12-31NZ$6.54 M44.58%
1996-12-31NZ$4.52 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Amgen
AMGN
NZ$94.49 B 111,541.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$88.35 B 104,289.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
NZ$71.43 M-15.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
NZ$16.81 B 19,762.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$73.57 B 86,834.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$29.55 B 34,817.68%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
NZ$55.43 B 65,391.36%๐Ÿ‡จ๐Ÿ‡ญ Switzerland